Sidmak Laboratories (India) Pvt. Ltd. was established in 1984 by its founders in technical collaboration with Sidmak Laboratories, Inc. in NJ USA.
We develop and manufacture innovative pharmaceutical products using its extensive experience and various technology platforms developed over last 25 years.
Having a vision to provide Quality healthcare to humanity and with special focus on essential and difficult to make medicine, Sidmak India, with its domestic presence spanning more than two decades has ambitious growth plans for catering to the global healthcare market.
With an asset of more than 500 qualified employees in Dehradun, Valsad and Mumbai and an expertise handling a range of formulations from tablets / capsules to Trans-dermal drug delivery dosage form, Sidmak India is poised for being among the fast growing pharmaceutical companies of India.
Pioneering efforts of Sidmak India in providing Quality medicines manufactured from world- class state-of-the-art manufacturing facilities and developed under the over sight of highly qualified and trained R&D team, make Sidmak India a valued partner for its domestic and international clients.
We value achievement of objectives and consistently strive towards our Vision, with perseverance.
We value knowledge such that it empowers our people to find innovative solutions to manage change.
We respect all our stakeholders.
These products are complex in nature either by its inherent bio availability issues or formulation patent protection. A dozen or so companies have track record in successfully developing such products using non infringing technology. The founders of Sidmak India has had great success with this approach in US Sidmak.
All products developed for USA customers are available to Sidmak India for markets other than USA, Canada and Mexico. The company intends to create strategic alliances for marketing these products in UK, Germany, France and other ROW markets.
These products are rather simple formulations and after expiration of basic molecule patent, have no further protection. More than 100 companies worldwide can easily develop these products for USA.